Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: Data of a preliminary study

OMICS A Journal of Integrative Biology

Volumn 15, Issue 6, 2011, Pages 369-374

  Balistreri, Carmela Rita ^a   Caruso, Calogero ^a   Carruba, Giuseppe ^a,b   Miceli, Vitale ^a,b   Candore, Giuseppina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b ARNAS Civico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; AGED; AGED, 80 AND OVER; AROMATASE; CASE-CONTROL STUDIES; COHORT STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SEQUENCE ANALYSIS, DNA; SICILY;

EID: 79958729830     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0128     Document Type: Article

References (27)

1. Balistreri, C.R., Carruba, G., Calabrò, M., Campisi, I., Di Carlo, D., Lio, D., et al. (2009). CCR5 proinflammatory allele in prostate cancer risk: a pilot study in patients and centenarians from Sicily. Ann N Y Acad Sci 1155, 289-292.
2. Balistreri, C.R., Caruso, C., and Candore, G. (2010a). The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. doi: 10.1155/2010/802078
3. Balistreri, C.R., Caruso, C., Carruba, G., Miceli, V., Campisi, I., List̀ý, F., et al. (2010b). A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications. Curr Pharm Des 16, 718-724.
4. Candore, G., Balistreri, C.R., Caruso, M., Grimaldi, M.P., Incalcaterra, E., List̀ý, F., et al. (2007a). Pharmacogenomics: a tool to prevent and cure coronary heart disease.Curr Pharm Des 13, 3726-3734.
5. Candore, G., Balistreri, C.R., Grimaldi, M.P., List̀ý, F., Vasto, S., Chiappelli, M., et al. (2007b). Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacoge-nomic approach. Mech Ageing Dev 128, 67-75. (Pubitemid 46073062)
6. Carruba, G. (2007). Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102, 899-911. (Pubitemid 350036930)
7. Caruso, C., Balistreri, C.R., Candore, G., Carruba, G., Colonna-Romano, G., Di Bona, D., et al. (2009). Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharma-cogenomic approach. Cancer Immunol Immunother 58, 1919-1933.
8. Cevenini, E., Invidia, L., Lescai, F., Salvioli, S., Tieri, P., Cas-tellani, G, et al. (2008). Human models of aging and longevity. Expert Opin Biol Ther 8, 1393-1405.
9. Chae, Y.K., Huang, H.Y., Strickland, P., Hoffman, S.C., and Helzlsouer, K. (2009). Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer. PLoS One 4, e6523
10. Crawford, E.D. (2009). Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 73, S4-S10.
11. Chrisofos, M., Papatsoris, A.G., Lazaris, A., and Deliveliotis, C. (2007). Precursor lesions of prostate cancer Crit Rev Clin Lab Sci. 44, 243-270. (Pubitemid 46525178)
12. Cussenot, O., Azzouzi, A.R., Nicolaiew, N., Fromont, G., Mangin, P., Cormier, L, et al. (2007). Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. J Clin Oncol 25, 3596-3602. (Pubitemid 47376605)
13. De Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C.G., et al. (2007). Inflammation in prostate carcino-genesis. Nat Rev Cancer 7, 256-269
14. Dianat, S.S., Margreiter, M., Eckersberger, E., Finkelstein, J., Kuehas, F., Herwig, R., et al. (2009). Gene polymorphisms and prostate cancer: the evidence. BJU Int 104, 1560-1572.
15. Ellem, S.J., and Risbridger, G.P. (2009). The dual, opposing roles of estrogen in the prostate. Ann N Y Acad Sci 1155, 174-186.
16. Ellem, S.J., and Risbridger, G.P. (2010). Aromatase and regulating the estrogen: androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 118, 246-251.
17. Ellem, S.J., Wang, H., Poutanen, M., and Risbridger, G.P (2009). Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 175, 1187-1199.
18. Esteban, E., Via, M., González-Pérez, E., Santamaŕýa, J., Du-goujon, J.M., Vona, G., et al. (2005). An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: data on the Mediterranean region. Am J Hum Biol 17, 690-695. (Pubitemid 43082482)
19. Huhtaniemi, I.T., Pye, S.R., Holliday, K.L., Thomson, W., O'Neill, T.W., Platt, H., et al. (2010). European Male Aging Study Group. Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men. J Clin Endocrinol Metab 95, 1898-1908.
20. Imyanitov, E.N. (2009). Use of elderly tumor-free subjects as a "supercontrol" for cancer epidemiological studies: pros and cons. Mech Ageing Dev 130, 122-127.
21. Ma, C.X., Adjei, A.A., Salavaggione, O.E., Coronel, J., Pelleymounter, L., Wang, L., et al. (2005). Human aromatase: gene resequencing and functional genomics. Cancer Res 65, 11071-11082. (Pubitemid 41713378)
22. McPherson, S.J., Ellem, S.J., and Risbridger, G.P. (2008). Estrogen-regulated development and differentiation of the prostate. Differentiation 76, 660-670. (Pubitemid 352032746)
23. Miller, S.A., Dykes, D.D., and Polesky, H.F (1998). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16, 1215.
24. Mononen, N., and Schleutker, J. (2009). Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer. J Urol 181, 1541-1549.
25. Modugno, F., Weissfeld, J.L., Trump, D.L., Zmuda, J.M., Shea, P., Cauley, J.A., et al. (2001). Allelic variants of aromatase and the androgen and estrogen receptors: toward a multi-genic model of prostate cancer risk. Clin Cancer Res 7, 3092-3096. (Pubitemid 32963829)
26. Platz, E.A., and Giovannucci, E. (2004). The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92, 237-253. (Pubitemid 40128245)
27. Ricke, W.A., Wang, Y., and Cunha, G.R (2007). Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Differentiation 75, 871-882. (Pubitemid 350086172)